Ronny Drapkin
Affiliations: | University of Pennsylvania Perelman School of Medicine |
Website:
https://www.med.upenn.edu/apps/faculty/index.php/g20000320/p8790102Google:
"Ronny Drapkin"Mean distance: (not calculated yet)
Parents
Sign in to add mentor| James E. Haber | research assistant | 1990 | Brandeis (Chemistry Tree) | |
| (BA) | ||||
| Danny Reinberg | grad student | 1996 | Univ. of Medicine & Dentistry of New Jersey (Chemistry Tree) | |
| David M. Livingston | post-doc | University of Pennsylvania Perelman School of Medicine | ||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Reavis HD, Gysler SM, McKenney GB, et al. (2024) Norepinephrine induces anoikis resistance in high-grade serous ovarian cancer precursor cells. Jci Insight |
| Bustos MA, Yokoe T, Shoji Y, et al. (2023) MiR-181a targets STING to drive PARP inhibitor resistance in BRCA- mutated triple-negative breast cancer and ovarian cancer. Cell & Bioscience. 13: 200 |
| Kinose Y, Xu H, Kim H, et al. (2023) Dual blockade of BRD4 and ATR/WEE1 pathways exploits loss in clear cell ovarian cancer. Research Square |
| Taylor MS, Wu C, Fridy PC, et al. (2023) Ultrasensitive detection of circulating LINE-1 ORF1p as a specific multi-cancer biomarker. Cancer Discovery |
| Ferrari AJ, Rawat P, Rendulich HS, et al. (2023) H2Bub1 loss is an early contributor to clear cell ovarian cancer progression. Jci Insight. 8 |
| Nameki RA, Chang H, Yu P, et al. (2023) Rewiring of master transcription factor cistromes during high-grade serous ovarian cancer development. Biorxiv : the Preprint Server For Biology |
| Taylor MS, Wu C, Fridy PC, et al. (2023) Ultrasensitive detection of circulating LINE-1 ORF1p as a specific multi-cancer biomarker. Biorxiv : the Preprint Server For Biology |
| Sato S, Gillette M, de Santiago PR, et al. (2023) LINE-1 ORF1p as a candidate biomarker in high grade serous ovarian carcinoma. Scientific Reports. 13: 1537 |
| Doberstein K, Spivak R, Reavis HD, et al. (2022) L1CAM is required for early dissemination of fallopian tube carcinoma precursors to the ovary. Communications Biology. 5: 1362 |
| Banerjee S, Drapkin R, Richardson DL, et al. (2022) Targeting NaPi2b in ovarian cancer. Cancer Treatment Reviews. 112: 102489 |